Alberta Investment Management Corp Aquestive Therapeutics, Inc. Transaction History
Alberta Investment Management Corp
- $8.96 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
139Shares Held
51.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$59.3 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$34.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$32.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$18 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$13.2 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $322M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...